Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks544759-BOM
resources
544759-BOM

Goldline Pharmaceutical Ltd.

BSE: 544759
SME
Sector: Healthcare
Industry: Pharmaceuticals
30.10+0.1 (+0.40%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Goldline Pharmaceutical Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2026
Annual ReportsFY 2026
Quarterly Results
Conference Calls—
Presentations—

Corporate Announcements and Regulatory Filings

Goldline Pharmaceutical Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201812 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) for quarter and half year ended September 30, 2026.
  2. Closure of Trading Window24 Sept 2026
    Closure of Trading Window
    Intimation of Closure of Trading window
  3. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20112 Sept 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Mujumdar
  4. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20112 Sept 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Mujumdar
  5. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 20111 Sept 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amol Laxmikant Mujumdar
  6. AGM31 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Scrutinizer Report
  7. AGM29 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    AGM Proceedings of the 22nd Annual General Meeting (AGM) of the Company pertaining to Financial Year 2025-26.
  8. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201129 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Swapan Khandelwal
  9. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201129 Aug 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Swapan Khandelwal
  10. Newspaper Publication7 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Notice published by way of an advertisement in respect of 22nd Annual General Meeting (AGM) of the Company.
  11. Record Date6 Aug 2026
    Intimation Of Record Date For Remote E-Voting
    Intimation of Record Date for remote e-voting
  12. Book Closure6 Aug 2026
    Intimation Of Book Closure Shall Remain Closed From Sunday 23Rd August, 2026 To Saturday 29Th August, 2026 (Both Days Inclusive) For Taking Record Of The Members Of The Company For The Purpose Of 22Nd (Twenty Second) Annual General Meeting Of The Company Scheduled To Be Held Saturday 29Th August, 2026 At 04:00 P.M
    Intimation of Book Closure
  13. Reg. 34 (1) Annual Report6 Aug 2026
    Reg. 34 (1) Annual Report.
    Submission of Annual Report of Goldline Pharmaceutical Limited for FY 2025-26.
  14. AGM6 Aug 2026
    Intimation Of Notice Of 22Nd Annual General Meeting Of Goldline Pharmaceutical Limited Will Be Held On Saturday, 29Th August, 2026 At 4:00 P.M. At Hotel Airport Centre Point, 131/1, Adjacent To Airport, Wardha Road, Somalwada, Nagpur, Maharashtra 440025
    Intimation of notice of 22nd AGM of Goldline Pharmaceutical Limited.
  15. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201130 Jul 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prashant Shrikrishna Karkare
  16. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201820 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5)
  17. Change in Management14 Jul 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of M/s. Avinash Prakash Gandhewar, Practicing Company Secretaries, Membership No. FCS 11197 as Secretarial Auditor of the Company for the FY 2025-26.
  18. Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A24 Jun 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  19. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201124 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Swapan Khandelwal
  20. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201124 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Swapan Khandelwal

Frequently Asked Questions

Where can I download the annual report of Goldline Pharmaceutical Ltd.?
Annual reports of Goldline Pharmaceutical Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Goldline Pharmaceutical Ltd.?
Quarterly earnings results and presentations of Goldline Pharmaceutical Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Goldline Pharmaceutical Ltd. publish earnings call transcripts?
Earnings call transcripts of Goldline Pharmaceutical Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Goldline Pharmaceutical Ltd.?
Investor presentations and annual day presentations of Goldline Pharmaceutical Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Goldline Pharmaceutical Ltd.?
Corporate announcements and regulatory filings of Goldline Pharmaceutical Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Goldline Pharmaceutical Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Goldline Pharmaceutical Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Goldline Pharmaceutical Ltd.?
The ISIN (International Securities Identification Number) of Goldline Pharmaceutical Ltd. is INE1CLW01015. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Goldline Pharmaceutical Ltd. listed?
Goldline Pharmaceutical Ltd. is listed on NSE and BSE. The NSE symbol is 544759-BOM and the BSE code is -.
Where can I find the shareholding pattern of Goldline Pharmaceutical Ltd.?
The quarterly shareholding pattern of Goldline Pharmaceutical Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Goldline Pharmaceutical Ltd. on Sharpely?
Share price data for Goldline Pharmaceutical Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.